What is the recommended dosage of Nicorandil (Nicorandil) for treating angina?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nicorandil Dosage for Treating Angina

Nicorandil may be considered at a dosage of 10-20 mg twice daily for treating angina, though it is not a first-line agent and its safety in heart failure is uncertain. 1

Treatment Algorithm for Angina

First-Line Therapy

  • Beta-blockers are the preferred first-line treatment for angina due to their proven benefits in reducing heart failure hospitalization and mortality 1

Alternative Agents (When Beta-Blockers Cannot Be Used)

  1. Ivabradine (Class IIa, Level A) - for patients in sinus rhythm 1
  2. Oral or transcutaneous nitrates (Class IIa, Level A) 1
  3. Amlodipine (Class IIa, Level A) 1
  4. Nicorandil (Class IIb, Level C) - may be considered when beta-blockers cannot be tolerated 1
  5. Ranolazine (Class IIb, Level C) 1

Nicorandil Specific Dosing

  • Starting dose: 10 mg twice daily 2
  • Maintenance dose: 10-20 mg twice daily 2, 3
  • Maximum dose: Up to 40 mg daily in divided doses for patients requiring higher doses 4, 2
  • Administration: Twice-daily regimen provides sustained efficacy 2

Mechanism and Efficacy

Nicorandil is a potassium channel opener with nitrate-like properties that:

  • Causes sustained dilation of both arterial resistance and conductive vessels 4
  • Increases coronary blood flow 4
  • Has minimal effect on heart rate, blood pressure, or cardiac contractility at clinical doses 4
  • Provides balanced peripheral action that decreases both preload and afterload 2

The IONA (Impact Of Nicorandil in Angina) trial demonstrated that nicorandil 20 mg twice daily reduced major coronary events in patients with stable angina, with a 17% reduction in the primary composite endpoint of coronary heart disease death, non-fatal MI, or unplanned hospital admission for cardiac chest pain (p=0.014) 5.

Important Considerations

Safety Profile

  • Nicorandil's safety in heart failure is uncertain (Class IIb, Level C) 1
  • Main side effects are headaches, which typically occur early in treatment and can be minimized with gradual dose titration 2
  • Unlike calcium channel blockers, nicorandil does not have a depressant effect on atrioventricular conduction 4

Combination Therapy

  • Nicorandil may be added as a second anti-anginal drug when symptoms persist despite beta-blocker treatment 1
  • Caution: Combination of nicorandil with nitrates is NOT recommended due to lack of additional efficacy (Class III, Level C) 1
  • Caution: Combination of nicorandil with ivabradine or ranolazine is NOT recommended due to unknown safety (Class III, Level C) 1

Special Populations

  • May be effective in patients with rest and effort angina who do not respond to combination therapy with calcium antagonists and oral nitrates 4
  • In a pilot study of patients with unstable angina, nicorandil significantly reduced episodes of transient myocardial ischemia and arrhythmias 1

Clinical Pearls

  • Nicorandil has shown no evidence of developing tolerance with long-term use (up to 1 year) 2
  • The drug has both anti-ischemic and potential cardioprotective properties 5
  • Nicorandil is approved in many countries in Europe and Asia but not in the United States 1, 6

When managing angina, always prioritize beta-blockers first when possible, and consider nicorandil as an alternative or add-on therapy when first-line treatments are insufficient or contraindicated.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.